Fibromyalgia syndrome (FMS) may cause functional disability, severe pain and fatigue and affect quality of life (QoL)which interfere with daily activities of patients. Aim: To determine the association between body mass index (BMI) and symptom severity, QoL and functional capacity in patients with fibromyalgia. Participants and Methods: Fifty women (50) with fibromyalgia and thirty (30) age matched healthy women control group were assessed for BMI, socio-economic (SES) status assessment and clinical signs of fibromyalgia by FMS-related measurements, visual analogue scale (VAS), number of tender points (NTP) Fibromyalgia Impact Questionnaire (FIQ) and Myalgia score. The short form health survey -36, Functional capacity was conducted by six minute walk test. Results: The majority of patients were obese (74%): 48% class 1, 20% class 2, and 6 % class 3. Greater fibromyalgia-related symptoms and functional impairment were found in the higher BMI group with statistically significant differences regarding SES total score; education and culture total domain, NTP and myalgic score, 6 minutes' walk test, some domains of SF36 and leptin concentration. Severe FM showed higher VAS, NTP, Myalgic score, disease duration, BMI and leptin concentration but lower age and SES than other grades with statistically significant differences regarding disease duration VAS, myalgic score, leptin concentration and all SF36 domains except general health perception. Conclusion and Recommendation: The findings support that excess weight is negatively related to QOL, functional capacity , SES but positively related to disease severity (clinical and lab) in women with FMS. A fibromyalgia treatment program needs to incorporate medical and behavioral weight loss programs for obese patients
Introduction
Fibromyalgia (FM) is a debilitating, chronic illness characterized by chronic musculoskeletal widespread pain and a heightened and painful response to pressure 1 . Associated somatic symptoms may occur with psychiatric and stressrelated disorders 2 . Fibromyalgia symptoms may cause functional disability ,severe pain and fatigue and affect QOL which interfere with daily activities of patients 3 and account for the high indirect costs for society and an individual economic, social, educational and vocational burden 4 . FM is a common disorder with a monthly incidence that has been shown to reach 9-10% in the general population 5,6 and 2-8% prevalence (3% in women and 0.5% in men) 7 . It is usually considered a disorder of women 20-50 years, however it also occur in children, adolescents and older person 8 . Higher rates of people being overweight or obese, ranging from 47-73% have been reported in patients with fibromyalgia. BMI is an independent risk factor for fibromyalgia. Overweight or obese women had a 60-70% higher risk compared with women of normal weight 9 . Leptin is an adipocyte-derived hormone with evidence toward a role in the immune system and reduce the threshold for pain 10 . Its levels are influenced by BMI 11 . Although obesity is common in patients with fibromyalgia, how the degree of obesity impacts fibromyalgia-related; clinical symptoms and lab profile (leptin levels) and QOL has not been reported to date. The purpose of the present study is to examine the association of BMI and socioeconomic status (SES), symptoms severity, QOL and functional capacity in patients with fibromyalgia and to evaluate the possibility of an alteration in levels of leptin patients suffering from fibromyalgia, a prototypical disorder of central pain processing
Participants and Methods:
This is a two phases study; phase one is a case control study which was carried out on fifty female patients with primary fibromyalgia who fulfilled the recent preliminary diagnostic Criteria The final scale included 7 domains with a total score of 84, with a higher score indicating better SES. Socioeconomic level was classified into four levels depending on the quartiles of the score calculated 14 .
B-FMS-Related Measurements: 1-Visual analogue scale (VAS):
Widespread Pain will be assessed by pain score (0-10 cm), with higher scores indicating more pain. The score was obtained by measuring the line in centimeters from 0 to the point marked by the patient. 15 2-Number of tender points (NTP): It would be determined by applying a pressure with the thumb on 18 specific body points, and the NTP was recorded 16 . 3-Myalgic score (MS): is a rating given by the physician to describe the sensitivity of a tender point when pressure is applied. The physician determined the number of active tender points and rated the sensitivity of the pain on a scale of 0 (no pain) to 3 (withdrawal of the patient from the examiner) of each tender point to determine a myalgic score 17 . 
4-Serum leptin:

D-Functional capacity:
Six minute walk test is used for objective assessment of functional performance. The subjects were instructed to walk their maximum distance in a 6-min period. The total distance covered in meters during the 6 min of walking was used as the score for each session 20 .
Statistical analysis:
The collected data were tabulated and analyzed using SPSS version 16 soft ware. The data were expressed as mean and standard deviation for continuous data and number and percentages for numerical data. continuous variables were compared across the BMI groups through one way analysis of variance (ANOVA). The accepted level of significance in this work was 0.05 (2 sided P value < 0.05 was considered significant). differences only on family possession and family domain. Health-related QOL of FM patients and obese control groups are shown in figure 2 . All the dimensions of QOL, as measured by SF-36 subscales ,were significantly worse in the obese FM patients group compared to the obese control group (p < 0.001).
Results
This study included 2 groups
Comparison of the functional capacity of the two groups are showed in figure  3 . Functional capacity test (six minute walk test) were significantly impaired in obese FM patients group compared to the obese control group (p <0.001).
The majority of patients were obese (74%) distributed as (48%) class 1, (20%) class 2 , and (6%) class 3, there were statistically significant differences between patients' body mass index categories regarding SES total score (p < 0.05) and education and culture total domain (p < 0.001).
Obesity grade I showed a higher (total socio-economic scale, education and culture) scores than normal weight and other grades of obesity. (table 1) FIQ score, NTP, VAS, myalgic score , functional capacity and leptin concentration comparison by BMI category are reported in Table2. There were significant group differences except for VAS (p > 0.05). Obesity grade III showed higher VAS, myalgic score, NTP, FIQ Score and leptin concentration. While Normal weight showed higher 6 minute walk test than other obesity grades ( Table 2) . Health-related QOL as expressed by SF36 by obesity status is shown in Table 3 . There are, group differences with the lower SF-36 scores in the higher BMI groups indicating poorer QOL in all subscales except for physical function, physical component summary, physical role and bodily pain no significant differences between obesity status groups were found. Normal weight showed higher (physical function, pain index, general health perception, vitality, social function, physical component) than other obesity grades (Table 3) . Regarding severity of fibromyalgia, more than half (56%) of patients were average to high grade with equal distribution (22%) of the other grades; below average and severe. Disease duration, BMI, VAS, NTP, Myalgic score , 6 minute walk test and leptin concentration were worse across grades of severity of FM ( Potential mechanisms that may explain the association between fibromyalgia and obesity include a higher level of pain receptors in fat tissue, alterations in the endogenous opioid system, elevated serum levels of pro inflammatory cytokines, thyroid dysfunction and increased mechanical loads associated with greater BMI. 32 This study revealed that obesity grade III showed lower (total socio-economic scale, education and culture, economic domains) than normal weight and other grades of obesities and lower socio economic score was associated with more severe symptoms of FMS .this agrees with many studies. 42 . Morbidly obese patients with FM had a significantly higher frequency of low back and musculoskeletal pain than lean patients. 43 FIQ is the most widely used tool for measuring quality of life in patients with FM according to Assumpcao et al., 2010. 44 In our study total score of FIQ was significantly increased in obese fibromyalgia patients grade III which agree with many studies. Our study showed that increasing of BMI is associated with higher levels of fibromyalgia symptoms. Also disease duration, visual analogue scale [VAS], (more pain intensity and increase fatigue) and myalgic score were significantly increase in sever FM patients. The association of symptom severity with severe or morbid obesity also has been noted in other conditions.
30
Morbidly obese patients had significantly higher frequency of low back and other musculoskeletal pain than lean patients, and the lowest QOL scores were observed in the morbidly obese patients compared with other BMI strata. 51, 53 In survey by Schaever et al. (2011) 42 it was reported that FM severity level was very important for evaluation of FM treatment and priority setting of health care. Musculoskeletal symptoms, functional disability and QOL, as well as fibromyalgia symptoms in overweight and obese, have been shown to improve with weight reduction measures.
Conclusion
Obesity is common in patients with fibromyalgia, 74% of our patients were obese and 6% were severely obese A greater BMI is associated with higher levels of fibromyalgia symptoms and pain, as well as lower levels of QOL and physical performance, higher VAS and Myalgic score than non obese or overweight patients.
Recommendations:
Keeping a normal-weight status and to avoid overweight or obese status could be a useful way to improve FM patients symptoms, QOL, and functional capacity. 
